Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:chylomicrons:prthr:pt:plr fld:ord'
(id=9196208 ; fe=en:chylomicrons:prthr:pt:plr fld:ord ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1537 creation date=2017-11-05 touchdate=2024-09-18 10:56:58.000)
≈ 49 relations sortantes

  1. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:17-hydroxycorticosteroids:mrat:24h:urine:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:17-hydroxycorticosteroids:mrat:24h:urine:qn | rel=r_associated | relid=0 | w=20
  2. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:17-hydroxycorticosteroids:scnc:24h:urine:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:17-hydroxycorticosteroids:scnc:24h:urine:qn | rel=r_associated | relid=0 | w=20
  3. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:17-hydroxycorticosteroids:scnc:pt:urine:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:17-hydroxycorticosteroids:scnc:pt:urine:qn | rel=r_associated | relid=0 | w=20
  4. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:17-hydroxycorticosteroids:srat:24h:urine:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:17-hydroxycorticosteroids:srat:24h:urine:qn | rel=r_associated | relid=0 | w=20
  5. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:17-ketogenic steroids:mcnc:24h:urine:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:17-ketogenic steroids:mcnc:24h:urine:qn | rel=r_associated | relid=0 | w=20
  6. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:17-ketogenic steroids:mrat:72h:urine:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:17-ketogenic steroids:mrat:72h:urine:qn | rel=r_associated | relid=0 | w=20
  7. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:17-ketogenic steroids:scnc:24h:urine:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:17-ketogenic steroids:scnc:24h:urine:qn | rel=r_associated | relid=0 | w=20
  8. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:17-ketogenic steroids:srat:24h:urine:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:17-ketogenic steroids:srat:24h:urine:qn | rel=r_associated | relid=0 | w=20
  9. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:17-ketosteroids:mcnc:24h:urine:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:17-ketosteroids:mcnc:24h:urine:qn | rel=r_associated | relid=0 | w=20
  10. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:17-ketosteroids:mcnc:pt:ser:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:17-ketosteroids:mcnc:pt:ser:qn | rel=r_associated | relid=0 | w=20
  11. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:17-ketosteroids:scnc:24h:urine:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:17-ketosteroids:scnc:24h:urine:qn | rel=r_associated | relid=0 | w=20
  12. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:17-ketosteroids:scnc:pt:urine:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:17-ketosteroids:scnc:pt:urine:qn | rel=r_associated | relid=0 | w=20
  13. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:17-ketosteroids:srat:24h:urine:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:17-ketosteroids:srat:24h:urine:qn | rel=r_associated | relid=0 | w=20
  14. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:18-hydroxycorticosterone:mcnc:pt:urine:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:18-hydroxycorticosterone:mcnc:pt:urine:qn | rel=r_associated | relid=0 | w=20
  15. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:18-hydroxycorticosterone:scnc:pt:ser/plas:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:18-hydroxycorticosterone:scnc:pt:ser/plas:qn | rel=r_associated | relid=0 | w=20
  16. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:3-hydroxyisovalerate:prthr:pt:urine:ord
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:3-hydroxyisovalerate:prthr:pt:urine:ord | rel=r_associated | relid=0 | w=20
  17. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:4-hydroxyphenylpyruvate:prthr:pt:urine:ord
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:4-hydroxyphenylpyruvate:prthr:pt:urine:ord | rel=r_associated | relid=0 | w=20
  18. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:5-hydroxyindoleacetate:prthr:pt:urine:ord
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:5-hydroxyindoleacetate:prthr:pt:urine:ord | rel=r_associated | relid=0 | w=20
  19. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:acute kidney injury risk:likelihood:pt:^patient:qn:calculated.nephrocheck
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:acute kidney injury risk:likelihood:pt:^patient:qn:calculated.nephrocheck | rel=r_associated | relid=0 | w=20
  20. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:alkaline phosphatase.heat stable:prthr:pt:ser/plas:ord:heat stability
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:alkaline phosphatase.heat stable:prthr:pt:ser/plas:ord:heat stability | rel=r_associated | relid=0 | w=20
  21. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:alkaline phosphatase.intestinal:prthr:pt:ser/plas:ord
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:alkaline phosphatase.intestinal:prthr:pt:ser/plas:ord | rel=r_associated | relid=0 | w=20
  22. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:alpha aminoadipate:scnc:24h:urine:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:alpha aminoadipate:scnc:24h:urine:qn | rel=r_associated | relid=0 | w=20
  23. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:alpha aminoadipate:scnc:pt:amnio fld:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:alpha aminoadipate:scnc:pt:amnio fld:qn | rel=r_associated | relid=0 | w=20
  24. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:alpha aminoadipate:scnc:pt:bld.dot:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:alpha aminoadipate:scnc:pt:bld.dot:qn | rel=r_associated | relid=0 | w=20
  25. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:alpha aminoadipate:scnc:pt:body fld:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:alpha aminoadipate:scnc:pt:body fld:qn | rel=r_associated | relid=0 | w=20
  26. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:alpha aminoadipate:scnc:pt:csf:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:alpha aminoadipate:scnc:pt:csf:qn | rel=r_associated | relid=0 | w=20
  27. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:alpha aminoadipate:scnc:pt:ser/plas^fetus:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:alpha aminoadipate:scnc:pt:ser/plas^fetus:qn | rel=r_associated | relid=0 | w=20
  28. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:alpha aminoadipate:scnc:pt:ser/plas:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:alpha aminoadipate:scnc:pt:ser/plas:qn | rel=r_associated | relid=0 | w=20
  29. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:alpha aminoadipate:scnc:pt:urine:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:alpha aminoadipate:scnc:pt:urine:qn | rel=r_associated | relid=0 | w=20
  30. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:alpha-2-macroglobulin:prthr:pt:urine:ord:immunoelectrophoresis
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:alpha-2-macroglobulin:prthr:pt:urine:ord:immunoelectrophoresis | rel=r_associated | relid=0 | w=20
  31. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:ammonium urate/total:mass fraction:point in time:calculus (stone):quantitative
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:ammonium urate/total:mass fraction:point in time:calculus (stone):quantitative | rel=r_associated | relid=0 | w=20
  32. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:androstanolone:prthr:pt:ser/plas:ord
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:androstanolone:prthr:pt:ser/plas:ord | rel=r_associated | relid=0 | w=20
  33. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:anserine+carnosine+cysteine+histidine+ornithine:prthr:pt:urine:ord
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:anserine+carnosine+cysteine+histidine+ornithine:prthr:pt:urine:ord | rel=r_associated | relid=0 | w=20
  34. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:apolipoprotein e1:prthr:pt:bld:ord
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:apolipoprotein e1:prthr:pt:bld:ord | rel=r_associated | relid=0 | w=20
  35. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:bilirubin:prthr:pt:amnio fld:ord
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:bilirubin:prthr:pt:amnio fld:ord | rel=r_associated | relid=0 | w=20
  36. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:calcium oxalate monohydrate crystals:prthr:pt:calculus:ord:infrared spectroscopy
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:calcium oxalate monohydrate crystals:prthr:pt:calculus:ord:infrared spectroscopy | rel=r_associated | relid=0 | w=20
  37. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:carbonate:prthr:pt:calculus:ord
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:carbonate:prthr:pt:calculus:ord | rel=r_associated | relid=0 | w=20
  38. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:collagen crosslinked n-telopeptide/creatinine:srto:24h:urine:qn:ia
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:collagen crosslinked n-telopeptide/creatinine:srto:24h:urine:qn:ia | rel=r_associated | relid=0 | w=20
  39. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:cortisol^2nd specimen:prthr:pt:saliva:ord
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:cortisol^2nd specimen:prthr:pt:saliva:ord | rel=r_associated | relid=0 | w=20
  40. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:creatine kinase:prthr:pt:body fld:ord
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:creatine kinase:prthr:pt:body fld:ord | rel=r_associated | relid=0 | w=20
  41. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:cytokines:prthr:pt:xxx:ord
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:cytokines:prthr:pt:xxx:ord | rel=r_associated | relid=0 | w=20
  42. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:dehydroascorbate:substance concentration:point in time:serum/plasma:quantitative
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:dehydroascorbate:substance concentration:point in time:serum/plasma:quantitative | rel=r_associated | relid=0 | w=20
  43. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:deprecated 17-ketogenic steroids:mass concentration:point in time:whole blood:quantitative
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:deprecated 17-ketogenic steroids:mass concentration:point in time:whole blood:quantitative | rel=r_associated | relid=0 | w=20
  44. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:estradiol:mcnc:pt:ser/plas:qn:ia
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:estradiol:mcnc:pt:ser/plas:qn:ia | rel=r_associated | relid=0 | w=20
  45. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:ketones:prthr:pt:urine:ord:test strip
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:ketones:prthr:pt:urine:ord:test strip | rel=r_associated | relid=0 | w=20
  46. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:post-discharge provider practice address:address:point in time:provider:nominal
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:post-discharge provider practice address:address:point in time:provider:nominal | rel=r_associated | relid=0 | w=20
  47. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:vascular endothelial growth factor d:mcnc:pt:ser/plas:qn
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:vascular endothelial growth factor d:mcnc:pt:ser/plas:qn | rel=r_associated | relid=0 | w=20
  48. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:x-linked adrenoleukodystrophy newborn screening comment-discussion:txt:pt:bld.dot:nar
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:x-linked adrenoleukodystrophy newborn screening comment-discussion:txt:pt:bld.dot:nar | rel=r_associated | relid=0 | w=20
  49. en:chylomicrons:prthr:pt:plr fld:ord -- r_associated #0: 20 / 1 -> en:x-linked adrenoleukodystrophy:imp:pt:bld.dot:nom
    n1=en:chylomicrons:prthr:pt:plr fld:ord | n2=en:x-linked adrenoleukodystrophy:imp:pt:bld.dot:nom | rel=r_associated | relid=0 | w=20
≈ 49 relations entrantes

  1. en:alpha aminoadipate:scnc:pt:ser/plas^fetus:qn --- r_associated #0: 39 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:alpha aminoadipate:scnc:pt:ser/plas^fetus:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=39
  2. en:deprecated 17-ketogenic steroids:mass concentration:point in time:whole blood:quantitative --- r_associated #0: 38 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:deprecated 17-ketogenic steroids:mass concentration:point in time:whole blood:quantitative | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=38
  3. en:17-ketogenic steroids:srat:24h:urine:qn --- r_associated #0: 37 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:17-ketogenic steroids:srat:24h:urine:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=37
  4. en:17-hydroxycorticosteroids:mrat:24h:urine:qn --- r_associated #0: 36 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:17-hydroxycorticosteroids:mrat:24h:urine:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=36
  5. en:17-ketosteroids:mcnc:24h:urine:qn --- r_associated #0: 35 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:17-ketosteroids:mcnc:24h:urine:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=35
  6. en:alpha aminoadipate:scnc:pt:csf:qn --- r_associated #0: 35 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:alpha aminoadipate:scnc:pt:csf:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=35
  7. en:ammonium urate/total:mass fraction:point in time:calculus (stone):quantitative --- r_associated #0: 35 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:ammonium urate/total:mass fraction:point in time:calculus (stone):quantitative | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=35
  8. en:ketones:prthr:pt:urine:ord:test strip --- r_associated #0: 35 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:ketones:prthr:pt:urine:ord:test strip | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=35
  9. en:17-hydroxycorticosteroids:scnc:24h:urine:qn --- r_associated #0: 34 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:17-hydroxycorticosteroids:scnc:24h:urine:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=34
  10. en:18-hydroxycorticosterone:scnc:pt:ser/plas:qn --- r_associated #0: 34 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:18-hydroxycorticosterone:scnc:pt:ser/plas:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=34
  11. en:4-hydroxyphenylpyruvate:prthr:pt:urine:ord --- r_associated #0: 34 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:4-hydroxyphenylpyruvate:prthr:pt:urine:ord | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=34
  12. en:alpha aminoadipate:scnc:pt:amnio fld:qn --- r_associated #0: 34 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:alpha aminoadipate:scnc:pt:amnio fld:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=34
  13. en:calcium oxalate monohydrate crystals:prthr:pt:calculus:ord:infrared spectroscopy --- r_associated #0: 34 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:calcium oxalate monohydrate crystals:prthr:pt:calculus:ord:infrared spectroscopy | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=34
  14. en:carbonate:prthr:pt:calculus:ord --- r_associated #0: 34 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:carbonate:prthr:pt:calculus:ord | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=34
  15. en:creatine kinase:prthr:pt:body fld:ord --- r_associated #0: 34 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:creatine kinase:prthr:pt:body fld:ord | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=34
  16. en:estradiol:mcnc:pt:ser/plas:qn:ia --- r_associated #0: 34 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:estradiol:mcnc:pt:ser/plas:qn:ia | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=34
  17. en:17-hydroxycorticosteroids:srat:24h:urine:qn --- r_associated #0: 32 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:17-hydroxycorticosteroids:srat:24h:urine:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=32
  18. en:17-ketogenic steroids:scnc:24h:urine:qn --- r_associated #0: 32 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:17-ketogenic steroids:scnc:24h:urine:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=32
  19. en:18-hydroxycorticosterone:mcnc:pt:urine:qn --- r_associated #0: 32 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:18-hydroxycorticosterone:mcnc:pt:urine:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=32
  20. en:5-hydroxyindoleacetate:prthr:pt:urine:ord --- r_associated #0: 32 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:5-hydroxyindoleacetate:prthr:pt:urine:ord | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=32
  21. en:alpha aminoadipate:scnc:24h:urine:qn --- r_associated #0: 32 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:alpha aminoadipate:scnc:24h:urine:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=32
  22. en:cortisol^2nd specimen:prthr:pt:saliva:ord --- r_associated #0: 32 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:cortisol^2nd specimen:prthr:pt:saliva:ord | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=32
  23. en:3-hydroxyisovalerate:prthr:pt:urine:ord --- r_associated #0: 31 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:3-hydroxyisovalerate:prthr:pt:urine:ord | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=31
  24. en:acute kidney injury risk:likelihood:pt:^patient:qn:calculated.nephrocheck --- r_associated #0: 31 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:acute kidney injury risk:likelihood:pt:^patient:qn:calculated.nephrocheck | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=31
  25. en:anserine+carnosine+cysteine+histidine+ornithine:prthr:pt:urine:ord --- r_associated #0: 31 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:anserine+carnosine+cysteine+histidine+ornithine:prthr:pt:urine:ord | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=31
  26. en:apolipoprotein e1:prthr:pt:bld:ord --- r_associated #0: 31 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:apolipoprotein e1:prthr:pt:bld:ord | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=31
  27. en:bilirubin:prthr:pt:amnio fld:ord --- r_associated #0: 31 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:bilirubin:prthr:pt:amnio fld:ord | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=31
  28. en:collagen crosslinked n-telopeptide/creatinine:srto:24h:urine:qn:ia --- r_associated #0: 31 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:collagen crosslinked n-telopeptide/creatinine:srto:24h:urine:qn:ia | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=31
  29. en:dehydroascorbate:substance concentration:point in time:serum/plasma:quantitative --- r_associated #0: 31 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:dehydroascorbate:substance concentration:point in time:serum/plasma:quantitative | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=31
  30. en:17-ketosteroids:mcnc:pt:ser:qn --- r_associated #0: 30 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:17-ketosteroids:mcnc:pt:ser:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=30
  31. en:alpha aminoadipate:scnc:pt:urine:qn --- r_associated #0: 30 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:alpha aminoadipate:scnc:pt:urine:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=30
  32. en:alpha-2-macroglobulin:prthr:pt:urine:ord:immunoelectrophoresis --- r_associated #0: 30 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:alpha-2-macroglobulin:prthr:pt:urine:ord:immunoelectrophoresis | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=30
  33. en:vascular endothelial growth factor d:mcnc:pt:ser/plas:qn --- r_associated #0: 30 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:vascular endothelial growth factor d:mcnc:pt:ser/plas:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=30
  34. en:x-linked adrenoleukodystrophy:imp:pt:bld.dot:nom --- r_associated #0: 30 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:x-linked adrenoleukodystrophy:imp:pt:bld.dot:nom | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=30
  35. en:17-hydroxycorticosteroids:scnc:pt:urine:qn --- r_associated #0: 29 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:17-hydroxycorticosteroids:scnc:pt:urine:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=29
  36. en:17-ketogenic steroids:mrat:72h:urine:qn --- r_associated #0: 29 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:17-ketogenic steroids:mrat:72h:urine:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=29
  37. en:17-ketosteroids:scnc:pt:urine:qn --- r_associated #0: 29 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:17-ketosteroids:scnc:pt:urine:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=29
  38. en:17-ketosteroids:srat:24h:urine:qn --- r_associated #0: 29 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:17-ketosteroids:srat:24h:urine:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=29
  39. en:alpha aminoadipate:scnc:pt:bld.dot:qn --- r_associated #0: 29 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:alpha aminoadipate:scnc:pt:bld.dot:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=29
  40. en:alpha aminoadipate:scnc:pt:body fld:qn --- r_associated #0: 29 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:alpha aminoadipate:scnc:pt:body fld:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=29
  41. en:17-ketosteroids:scnc:24h:urine:qn --- r_associated #0: 28 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:17-ketosteroids:scnc:24h:urine:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=28
  42. en:alkaline phosphatase.heat stable:prthr:pt:ser/plas:ord:heat stability --- r_associated #0: 28 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:alkaline phosphatase.heat stable:prthr:pt:ser/plas:ord:heat stability | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=28
  43. en:x-linked adrenoleukodystrophy newborn screening comment-discussion:txt:pt:bld.dot:nar --- r_associated #0: 28 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:x-linked adrenoleukodystrophy newborn screening comment-discussion:txt:pt:bld.dot:nar | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=28
  44. en:alpha aminoadipate:scnc:pt:ser/plas:qn --- r_associated #0: 27 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:alpha aminoadipate:scnc:pt:ser/plas:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=27
  45. en:post-discharge provider practice address:address:point in time:provider:nominal --- r_associated #0: 27 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:post-discharge provider practice address:address:point in time:provider:nominal | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=27
  46. en:17-ketogenic steroids:mcnc:24h:urine:qn --- r_associated #0: 26 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:17-ketogenic steroids:mcnc:24h:urine:qn | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=26
  47. en:alkaline phosphatase.intestinal:prthr:pt:ser/plas:ord --- r_associated #0: 26 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:alkaline phosphatase.intestinal:prthr:pt:ser/plas:ord | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=26
  48. en:androstanolone:prthr:pt:ser/plas:ord --- r_associated #0: 26 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:androstanolone:prthr:pt:ser/plas:ord | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=26
  49. en:cytokines:prthr:pt:xxx:ord --- r_associated #0: 26 --> en:chylomicrons:prthr:pt:plr fld:ord
    n1=en:cytokines:prthr:pt:xxx:ord | n2=en:chylomicrons:prthr:pt:plr fld:ord | rel=r_associated | relid=0 | w=26
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr